expert roundtables

Defining Oligometastatic Disease and Treatment Implications
Oncology

Defining Oligometastatic Disease and Treatment Implications

expert roundtables
By E. David Crawford, MD; Leonard Gomella, MD; Neal D. Shore, MD, FACS; Peter R. Carroll, MD, MPH
Survival Benefit and Quality of Life Outcomes in Prostate Cancer
Oncology

Survival Benefit and Quality of Life Outcomes in Prostate Cancer

expert roundtables
By Daniel J. George, MD; Glen Gejerman, MD; Oliver Sartor, MD; William K. Oh, MD
How Do Race and Specific Cancer Genes Factor Into the Treatment of Advanced Prostate Cancer?
Oncology

How Do Race and Specific Cancer Genes Factor Into the Treatment of Advanced Prostate Cancer?

expert roundtables
By Daniel J. George, MD; Glen Gejerman, MD; Oliver Sartor, MD; William K. Oh, MD
Novel Targets and Molecular Profiling in Prostate Cancer
Oncology

Novel Targets and Molecular Profiling in Prostate Cancer

expert roundtables
By Daniel J. George, MD; Oliver Sartor, MD; William K. Oh, MD
The Shift Toward Earlier Use of Life-Extending Therapies and Combinations in Advanced Prostate Cancer
Oncology

The Shift Toward Earlier Use of Life-Extending Therapies and Combinations in Advanced Prostate Cancer

expert roundtables
By Daniel J. George, MD; Glen Gejerman, MD; Oliver Sartor, MD; William K. Oh, MD
Load More